Balyasny Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-90,954
Closed -$80.6K 3439
2022
Q4
$80.6K Buy
90,954
+54,860
+152% +$72.8K ﹤0.01% 2277
2022
Q3
$57K Sell
36,094
-25,352
-41% -$57.5K ﹤0.01% 2463
2022
Q2
$124K Buy
+61,446
New +$106K ﹤0.01% 2258
2022
Q1
Sell
-13,805
Closed -$64K 3089
2021
Q4
$64K Buy
+13,805
New +$85.7K ﹤0.01% 2034
2021
Q2
Sell
-15,266
Closed -$126K 2624
2021
Q1
$126K Sell
15,266
-5,864
-28% -$61.9K ﹤0.01% 1618
2020
Q4
$144K Buy
+21,130
New +$170K ﹤0.01% 1241
2018
Q4
Sell
-103,252
Closed -$454K 1910
2018
Q3
$454K Buy
+103,252
New +$572K ﹤0.01% 1409

Other funds holding SRNE